Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy-Reference-Cited by-同舟云学术

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

Published:1995-05 Issue:5 Volume:45 Page:831-838
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Partin Alan W.,Mohler James L.,Piantadosi Steven,Brendler Charles B.,Sanda Martin G.,Walsh Patrick C.,Epstein Jonathan I.,Simons Jonathan W.,Marshall Fray F.

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Cancer statistics;Boring;Ca Cancer J Clin,1993

2. Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biology;Hsieh;Cancer Treat Rev,1993

3. Prostate-specific antigen as measure of disease outcome in metastatic hormone-refractory prostate cancer;Kelly;J Clin Oncol,1993

4. Therapeutic alternatives for hormoneefractory prostatic cancer;Scher,1992

5. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment;McCarthy;J Urol,1994

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of YTHDC2 contributes to the progression of prostate cancer and predicts poor outcomes in patients with prostate cancer;Journal of Biochemical and Molecular Toxicology;2023-01-16

2. Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer;Disease Markers;2022-05-02

3. Surgical management of high-risk, localized prostate cancer;Nature Reviews Urology;2020-11-10

4. Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting;Virchows Archiv;2019-05-16

5. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study;Asian Journal of Andrology;2017